Author:
Riedl Karen,Krysan Kostyantyn,Põld Mehis,Dalwadi Harnisha,Heuze-Vourc’h Nathalie,Dohadwala Mariam,Liu Ming,Cui Xiaoyan,Figlin Robert,Mao Jenny T,Strieter Robert,Sharma Sherven,Dubinett Steven M
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference206 articles.
1. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas;Achiwa;Clin. Cancer Res.,1999
2. The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery;Alaoui-Jamali;Drug Resist. Update,2003
3. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production: role of tumor-derived IL-10, TGF-beta and prostaglandin E2;Alleva;J. Immunol.,1994
4. Clinical significance of defective dendritic cell differentiation in cancer;Almand;Clin. Cancer Res.,2000
5. Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer;Altorki;J. Clin. Oncol.,2003
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献